GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (LTS:0D1W) » Definitions » 6-Month Share Buyback Ratio

Biophytis (LTS:0D1W) 6-Month Share Buyback Ratio : -101.54% (As of Jun. 2024 )


View and export this data going back to 2018. Start your Free Trial

What is Biophytis 6-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Biophytis's current 6-Month Share Buyback Ratio was -101.54%.

Competitive Comparison of Biophytis's 6-Month Share Buyback Ratio

For the Biotechnology subindustry, Biophytis's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biophytis's 6-Month Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biophytis's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Biophytis's 6-Month Share Buyback Ratio falls into.


;
;

Biophytis 6-Month Share Buyback Ratio Calculation

Biophytis's 6-Month Share Buyback Ratio for the quarter that ended in Jun. 2024 is calculated as

6-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2023 ) - Shares Outstanding (EOP) (Jun. 2024 )) / Shares Outstanding (EOP) (Dec. 2023 )
=(2.601 - 5.242) / 2.601
=-101.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biophytis  (LTS:0D1W) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Biophytis 6-Month Share Buyback Ratio Related Terms

Biophytis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (LTS:0D1W) » Definitions » 6-Month Share Buyback Ratio
Comparable Companies
XPAR:ALTHX XPAR:ALINT XPAR:GNRO XPAR:ALMDP XPAR:ALTME XPAR:ALNEV XPAR:ALOPM XPAR:ALTAO XPAR:ALVET XPAR:ALVIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BPTSY:USA ALBPS:France 6XB3:Germany
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Website
https://www.biophytis.com
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis Headlines

No Headlines